FDA 510(k) FDA class 1 Substantially Equivalent 🇺🇸 United States

VIRASTAT FITC-LABELED ANTI-INFLUENZA A AND B MONOCLONAL ANTIBODIES

K Number: K984596 · Decision Mar 4, 1999
Classifications
1
FEI Numbers
0
Registration Numbers
0
Same Product Code
0
Applicant Total
4
Review Days
66

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
VIRASTAT FITC-LABELED ANTI-INFLUENZA A AND B MONOCLONAL ANTIBODIES
K Number
K984596
Device Class
FDA class 1
Clearance Type
Traditional
Regulation Number
866.3330
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Zymetx, Inc.
Date Received
December 28, 1998
Decision Date
March 4, 1999
Product Code
GNR
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
GNR Antisera, Neutralization, Influenza Virus A, B, C

Other Clearances by Zymetx, Inc.

K Number Device Name
K982429 ZSTATFLU TEST FOR INFLUENZA TYPES A AND B VIRUSES
K971494 VIRAZYME INFLUENZA ID TEST FOR INFLUENZA TYPES A AND B VIRUSES
K950838 VIRAZYME CULTURE CONFIRMATION SCREEN FOR INFLUENZA AND PARAINFLUENZA VIRUSES